Janssen Vaccines Corporation

Form 483 issued March 10, 2022 · Incheon, South Korea

Inspection
Mar 2 – Mar 10, 2022
Investigator
Melissa Ray
Observations
8
Pages
3
FEI number
3012637764

In short: On March 10, 2022, FDA issued a Form 483 with 8 observations to Janssen Vaccines Corporation in Incheon, Yeonsu-gu (FEI 3012637764) after an inspection that ran Mar 2 – Mar 10, 2022. The investigator was Melissa Ray. Most observations concern production and quality system; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

5 of 8 observations on this 483 concern production.

Production5
Quality system1
Facilities & equipment1
Laboratory controls1

Most cited: 21 CFR 211.113 (5×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not…

  2. 02

    Visual inspection program for…

  3. 03

    Validation for equipment used in the manufacturing of…

  4. 04

    Aseptic processing areas are deficient regarding the system…

4 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Janssen Vaccines Corporation?

FDA listed 8 observations on this Form 483, mostly about production, quality system and facilities & equipment. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Janssen Vaccines Corporation?

Melissa Ray is named on this Form 483, for the inspection of Mar 2 – Mar 10, 2022. Each investigator has a profile showing what they cite most.

When was Janssen Vaccines Corporation inspected by FDA?

The inspection ran Mar 2 – Mar 10, 2022, and the Form 483 is dated March 10, 2022.

How do I get the full Form 483 for Janssen Vaccines Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free